AI in Drug Discovery
AI-assisted drug discovery: AlphaFold, generative chemistry, target identification, clinical trial optimization and pharma company moves, tracked with clinical context.
Pathology AI and the quiet industrialisation of diagnosis
Why pathology AI depends first on digital slide infrastructure, scanner quality, reporting rules and professional trust.
Oncology AI and the economics of precision care
Oncology AI is valuable when it makes precision care usable and access-aware: molecular interpretation, trial matching and tumour-board synthesis must change real decisions.
AI drug discovery after AlphaFold: what changes, what does not
AlphaFold 3 strengthens AI drug discovery by improving structural and interaction hypotheses; it does not replace experimental validation or clinical trials.
Pharma strategy in the medical AI era
Pharma strategy in the medical AI era with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
Latest drug discovery AI developments
Clinical-trial recruitment AI and the ethics of speed
Clinical-trial recruitment AI and the ethics of speed with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
Biology foundation models and the new R&D stack
Biology foundation models and the new R&D stack with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
AlphaFold 3 renews the debate on AI’s role in drug discovery
AlphaFold 3 can accelerate research hypotheses in drug discovery, but it does not bypass experimental validation or clinical trials.
Clinical trial matching AI gains attention as recruitment costs rise
Clinical trial matching AI gains attention as recruitment costs rise with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
Pharma’s AI story moves from discovery hype to portfolio discipline
Pharma’s AI story moves from discovery hype to portfolio discipline with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
AI for antimicrobial stewardship gains urgency
AI for antimicrobial stewardship gains urgency with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
Primary sources tracked by DoktorClub editors
Trusted sources the DoktorClub editorial team monitors for this cluster: